MD Anderson at Cooper Cancer Center — Camden, New Jersey

MD Anderson at Cooper Cancer Center is a clinical research site located in Camden, New Jersey, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson at Cooper Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson at Cooper Cancer Center?

MD Anderson at Cooper Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson at Cooper Cancer Center conducted?

MD Anderson at Cooper Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Is MD Anderson at Cooper Cancer Center accredited by Crixeo Health?

MD Anderson at Cooper Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson at Cooper Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.